Identa Corp (IDTA) fair value: what the stock is really worth
As of Oct 13, 2026: fair value (intrinsic value) of Identa Corp stock $0.21, price $0.35, that is 40.0% below the price, quality 47 out of 100. Rating: strongly overvalued. Calculated from audited financials with 21 of our 26 valuation models and 37 quality factors, updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
Identa Corp
IDTA · USOur calculation puts a fair price 40% below what the stock costs today.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 8, 2026.
How to read this chart
60‑month range $0.1000 – $2.70 · fair‑value band $0.1500 – $0.3600 · the $0.3500 price screens above the $0.2100 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). 1 fiscal year is left out: there the valuation rested on only a fraction of the usual models. As of Nov 8, 2026.
Every Wednesday you see whether Identa is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
IDenta Corp. operates as a detection and forensic science company. The company offers drug, and explosives testing kits; aero chamber sniffer; forensic; and urine, and saliva drug testing products.
Show moreShow less
It provides its solutions to law enforcement, military, and government agencies, as well as other organizations that deal in fighting illicit drugs and terrorist threats.
The company has operations in Israel, the United States, the United Nations, DEA, Germany, France, Italy, Spain, Indonesia, Brazil, Mexico, South Africa, Australia, Canada, and internationally. IDenta Corp. was founded in 2002 and is headquartered in Jerusalem, Israel.
Stock analysis
Identa Corp (IDTA) currently trades at $0.3500, while our model-based Fair Value estimate is $0.2100, 40% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of $0.3900 per share, and 7 of the 21 models we run sit above the $0.3500 price.
Bear case: the Asset-Based group reads lowest at $0.1200, and 14 of the 21 models stay below the price. Data coverage for this calculation is low.
Scenario range: $0.1500 (bear) to $0.3600 (bull), the price of $0.3500 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 47/100 (below-average quality), in the Healthcare sector.
Weak Growth: Revenue is shrinking: the last year, the last three and the last five years are all negative.
Identa Corp reported revenue of $1.4M in FY2025 versus $1.4M in FY2021, a compound −0.7%/yr. Reported net income was $99.0K in FY2025, compounding +9.4%/yr from FY2021.
Key figures
Market cap $1.5M Micro · P/E ratio 17.5 · P/S ratio 1.28 · EPS (TTM) $0.0200 · Net margin 7.3% · Return on equity 13.8% · Return on assets (EBIT) 10.6% (5-year average) · Operating margin 4.7%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 43 out of 100 (low confidence).
What moves the price
The share trades about 2% below its 52-week high and 132% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −9% fair-value upside, at −40%, IDTA screens richer than that median.
Fair Value models
All 21 models by family
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
Growth Forecast
IDTA screens overvalued: fair value 40% below the price. Compare with Thermo Fisher Scientific Inc →
Compare Identa Corp with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Diagnostics & Research · 126 stocks
Valuation Multiplesvs Diagnostics & Research median · lower = cheaper
Strength profile in five axes (Snowflake)
VALUE 0: the price sits above our fair-value range.
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- Debt-to-equity by industry
- Price/FCF by industry
- PEG screener for stocks with fair value
- Undervalued stocks: US Stocks
- Valuation of the USA market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Diagnostics & Research stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| WuXi AppTec Co 603259 | ¥147.00 | ¥164.66 | +12% | vs IDTA |
| IQVIA Holdings IQV | $271.83 | $299.01 | +10% | vs IDTA |
| Illumina, Inc ILMN | $213.13 | $234.44 | +10% | vs IDTA |
| Thermo Fisher Scientific Inc TMO | $694.76 | $686.04 | −1% | vs IDTA |
| Danaher Corporation DHR | $230.25 | $209.18 | −9% | vs IDTA |
| IDEXX Laboratories, Inc IDXX | $676.04 | $496.48 | −27% | vs IDTA |
| Mettler-Toledo International Inc MTD | $1,722 | $655.06 | −62% | vs IDTA |
| Agilent Technologies, Inc A | $174.76 | $64.53 | −63% | vs IDTA |
| Lonza Group LONN | CHF 663.40 | CHF 153.50 | −77% | vs IDTA |
| Waters Corporation WAT | $457.60 | $91.26 | −80% | vs IDTA |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Identa Corp (IDTA) overvalued or undervalued?
What is the fair value of IDTA?
What is the quality score of IDTA?
What is the price target for Identa Corp (IDTA)?
What is the Identa Corp stock forecast for 2026?
What is the revenue of Identa Corp (IDTA)?
What growth is priced into Identa Corp (IDTA)?
What discount rate (WACC) does the fair value of IDTA use?
What is a reverse DCF?
How much growth has Identa Corp (IDTA) delivered so far?
How fast is the sector of Identa Corp (IDTA) growing?
What is the free cash flow yield of Identa Corp (IDTA)?
What is the intrinsic value of Identa Corp (IDTA)?
Is Identa Corp stock overvalued or undervalued in 2026?
Is fair value the same as the market price of IDTA?
How much is Identa Corp worth?
What do the bullish and bearish scenarios say about IDTA?
What is the P/E ratio of IDTA?
How solid is the balance sheet of Identa Corp (IDTA)?
How far is IDTA from its 52-week high?
Which stocks are comparable to Identa Corp?
Is Identa Corp stock attractive at the current price?
How is the fair value of IDTA calculated?
Is it still worth investing in stocks now?
What is the share price of Identa Corp (IDTA)?
What should I pay attention to with Identa Corp right now?
Key figures of Identa Corp
How large is the market capitalisation of Identa Corp (IDTA)?
What is the P/S ratio of Identa Corp (IDTA)?
What are the earnings per share of Identa Corp (IDTA)?
What is the net margin of Identa Corp (IDTA)?
What is the return on equity of Identa Corp (IDTA)?
What is the EBIT return on assets of Identa Corp (IDTA)?
What is the operating margin of Identa Corp (IDTA)?
How fast is revenue growing at Identa Corp (IDTA)?
How fast are earnings growing at Identa Corp (IDTA)?
How much net debt does Identa Corp (IDTA) carry?
Watch Identa Corp in the live analysis
One click puts Identa Corp on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.